Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPFG.L Regulatory News (PFG)

  • There is currently no data for PFG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Provident Financial Plc

12 Mar 2019 10:13

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Marathon Asset Management LLP
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Provident Financial Plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:
(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 March 2019
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES

If YES, specify which: Non-Standard Finance plc

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary shares

Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: 14,045,656 5.55 0 0
(2) Cash-settled derivatives: 0 0 0 0
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 0 0 0 0

TOTAL:

14,045,656* 5.55 0 0

* Marathon Asset Management LLP does not have discretion regarding voting decisions in respect of 4,065,756 shares that are included in the total above.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security Purchase/sale Number of securities Price per unit
Ordinary shares Sale 1,110 5.7000

(b) Cash-settled derivative transactions

Class of relevant security Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure: 12 March 2019
Contact name: Mary Davidge
Telephone number*: 0207 497 2211

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk

View source version on businesswire.com: https://www.businesswire.com/news/home/20190312005399/en/

Copyright Business Wire 2019

Date   Source Headline
2nd Mar 20234:30 pmRNSCompany name change
28th Feb 20234:30 pmRNSTotal Voting Rights
31st Jan 20234:30 pmRNSTotal Voting Rights
31st Jan 20237:00 amRNSHolding(s) in Company
26th Jan 20237:00 amRNSPFG appoints Ian McLaughlin as new CEO
26th Jan 20237:00 amRNSQ4 Trading Update, Product Launch and Name Change
24th Jan 20233:05 pmRNSHolding(s) in Company
13th Jan 20233:00 pmRNSBlock listing Interim Review
4th Jan 20231:00 pmRNSDirector/PDMR Shareholding
30th Dec 20221:30 pmRNSTotal Voting Rights
30th Nov 20224:30 pmRNSTotal Voting Rights
8th Nov 20227:00 amRNSBlock Listing Application
4th Nov 202212:18 pmRNSFunding Update
3rd Nov 202211:18 amRNSHolding(s) in Company
31st Oct 20224:30 pmRNSTotal Voting Rights
19th Oct 20227:00 amRNSThird quarter 2022 trading update
3rd Oct 20221:15 pmRNSDirector/PDMR Shareholding
30th Sep 20224:30 pmRNSTotal Voting Rights
28th Sep 20227:00 amRNSDirector/PDMR Shareholding
26th Sep 20224:43 pmRNSHolding(s) in Company
16th Sep 20222:21 pmRNSHolding(s) in Company
31st Aug 20224:30 pmRNSTotal Voting Rights
29th Jul 20224:30 pmRNSTotal Voting Rights
27th Jul 20227:00 amRNSInterim results for six months ended 30 June 2022
15th Jul 20223:04 pmRNSBlock listing Interim Review
1st Jul 20221:00 pmRNSDirector/PDMR Shareholding
30th Jun 20224:30 pmRNSTotal Voting Rights
29th Jun 20224:10 pmRNSProvident Financial plc Result of AGM
31st May 20224:30 pmRNSTotal Voting Rights
26th May 20224:25 pmRNSHolding(s) in Company
19th May 20227:00 amRNSProvident Financial plc Q1 2022 Trading Statement
11th May 202211:41 amRNSHolding(s) in Company
3rd May 202210:49 amRNSTotal Voting Rights
21st Apr 202211:32 amRNSDirector/PDMR Shareholding
12th Apr 20224:28 pmRNSHolding(s) in Company
8th Apr 202211:15 amRNSDirector/PDMR Shareholding
7th Apr 20221:34 pmRNSPFG Annual Report and Accounts and AGM Notice
5th Apr 202212:30 pmRNSDirector/PDMR Shareholding
1st Apr 20223:58 pmRNSHolding(s) in Company
1st Apr 20222:00 pmRNSDirector/PDMR Shareholding
31st Mar 20224:30 pmRNSTotal Voting Rights
31st Mar 20227:00 amRNSPFG 2021 Preliminary Results Announcement
24th Mar 20227:00 amRNSAppointment of Managing Director of Cards
22nd Mar 202210:34 amRNSHolding(s) in Company
21st Mar 20229:54 amRNSHolding(s) in Company
28th Feb 20224:30 pmRNSTotal Voting Rights
21st Feb 20224:06 pmRNSDirector Declaration
3rd Feb 20223:51 pmRNSHolding(s) in Company
1st Feb 20225:26 pmRNSHolding(s) in Company
1st Feb 20228:04 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.